{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:23:47Z","timestamp":1761877427530,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cireng.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T13:38:44Z","timestamp":1613396324000},"page":"655-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Underestimation of invasive breast carcinoma in patients with initial diagnosis of ductal carcinoma in situ: Size matters"],"prefix":"10.1016","volume":"99","author":[{"given":"Alberto","family":"Bouz\u00f3n Alejandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Iglesias L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benigno","family":"Acea Nebril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lourdes","family":"Garc\u00eda Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlota Czestokowa","family":"D\u00edaz Carballada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Varela Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cireng.2021.02.006_bib0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cireng.2021.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/ajr.162.6.8191988","article-title":"Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings","volume":"162","author":"Evans","year":"1994","journal-title":"Am J Roentgenol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr."},{"key":"10.1016\/j.cireng.2021.02.006_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.amjsurg.2016.04.019","article-title":"Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis","volume":"213","author":"El Hage Chehade","year":"2017","journal-title":"Am J Surg."},{"key":"10.1016\/j.cireng.2021.02.006_bib0025","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Lyman","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology."},{"key":"10.1016\/j.cireng.2021.02.006_bib0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.breast.2012.11.002","article-title":"Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy","volume":"22","author":"Schulz","year":"2013","journal-title":"Breast."},{"key":"10.1016\/j.cireng.2021.02.006_bib0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10549-016-3783-2","article-title":"Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy","volume":"156","author":"van Roozendaal","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.cireng.2021.02.006_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5152\/dir.2015.14453","article-title":"Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions","volume":"22","author":"Gumus","year":"2016","journal-title":"Diagn Interv Radiol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0055","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archsurg.2010.243","article-title":"Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ","volume":"145","author":"Kurniawan","year":"2010","journal-title":"Arch Surg."},{"key":"10.1016\/j.cireng.2021.02.006_bib0060","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ejso.2019.01.015","article-title":"Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!","volume":"45","author":"Marques","year":"2019","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.cireng.2021.02.006_bib0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1259\/bjr\/30974918","article-title":"Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy","volume":"85","author":"Suh","year":"2012","journal-title":"Br J Radiol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1186\/s12885-019-6417-3","article-title":"Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy","volume":"19","author":"Lee","year":"2019","journal-title":"BMC Cancer."},{"key":"10.1016\/j.cireng.2021.02.006_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4048\/jbc.2011.14.4.301","article-title":"Ductal carcinoma in situ and sentinel lymph node biopsy","volume":"14","author":"Son","year":"2011","journal-title":"J Breast Cancer."},{"key":"10.1016\/j.cireng.2021.02.006_bib0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.breast.2005.08.007","article-title":"Sentinel lymph node biopsy for localised ductal carcinoma in situ?","volume":"14","author":"Veronesi","year":"2005","journal-title":"Breast."},{"key":"10.1016\/j.cireng.2021.02.006_bib0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0b013e31815b446b","article-title":"Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European insitute of oncology on 584 patients in 10 years","volume":"247","author":"Intra","year":"2008","journal-title":"Ann Surg."},{"key":"10.1016\/j.cireng.2021.02.006_bib0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jso.23273","article-title":"Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy","volume":"107","author":"Park","year":"2013","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0100","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","article-title":"Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema","volume":"17","author":"Goldberg","year":"2010","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0105","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/cncr.11761","article-title":"The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up","volume":"98","author":"Lara","year":"2003","journal-title":"Cancer."},{"key":"10.1016\/j.cireng.2021.02.006_bib0110","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1245\/s10434-019-07475-9","article-title":"Is sentinel lymph node biopsy required for a core biopsy diagnosis of ductal carcinoma in situ with microinvasion?","volume":"26","author":"Flanagan","year":"2019","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.cireng.2021.02.006_bib0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/bjs.11079","article-title":"Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ","volume":"106","author":"Magnoni","year":"2019","journal-title":"Br J Surg."},{"key":"10.1016\/j.cireng.2021.02.006_bib0120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast."},{"key":"10.1016\/j.cireng.2021.02.006_bib0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendal","year":"2017","journal-title":"BMC Cancer."},{"key":"10.1016\/j.cireng.2021.02.006_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results following commencement of the Intergroup-Sentinel-Mamma (INSEMA) trial","volume":"77","author":"Reimer","year":"2017","journal-title":"Geburtshilfe Frauenheilkd."}],"container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507721000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507721000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:53:42Z","timestamp":1761875622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173507721000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2173507721000326"],"URL":"https:\/\/doi.org\/10.1016\/j.cireng.2021.02.006","relation":{},"ISSN":["2173-5077"],"issn-type":[{"type":"print","value":"2173-5077"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underestimation of invasive breast carcinoma in patients with initial diagnosis of ductal carcinoma in situ: Size matters","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cireng.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ciresp.2020.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEC. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}